http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-108342-C2

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2004-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-108342-C2
titleOfInvention METHOD OF PREPARATION OF 4 - ((1R, 3S) -6-CHLORO-3-PHENYLINDAN-1-IL) -1,2,2-TRIMETHYLPIPERASINE OR ITS SALT (OPTIONS), CIS- (1S, 3S) -6-CHLORINE 3-PHENYLINDAN-1-OL, CIS- (1S, 3S) -3-REPLACED-5-CHLORINE-1-PHENYLINDAN AND TRANS-1 - ((1R, 3S) -6-CHLORINE-3-PHENYLINDAN-1-IL ) -3,3-DIMETHYLPIPERASINE
abstract The invention relates to methods for the preparation of 4 - ((1R, 3S) -6-chlorop-3-phenylindan-1-yl) -1,2,2-trimethylpiperazine hydrosuccinate and hydromalonate salts thereof. Also described are pharmaceutical compositions containing said salts their use in medicine, including use in the treatment of schizophrenia and other psychotic diseases.
priorityDate 2003-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID610821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416038503

Total number of triples: 16.